Davidson Kempner Capital Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-325,000
Closed -$9.81M 210
2016
Q2
$9.81M Buy
+325,000
New +$6.59M 0.23% 82

Davidson Kempner Capital Management's CPXX Position: Q3 2016 in Review

Davidson Kempner Capital Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 325,000 shares — an estimated $9.81M sold.

Davidson Kempner Capital Management first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $9.81M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Davidson Kempner Capital Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 325,000 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $9.81M.
  • Davidson Kempner Capital Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • Davidson Kempner Capital Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $9.81M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Davidson Kempner Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.